Abeona Therapeutics Inc expected to post a loss of 75 cents a share - Earnings Preview

Abeona Therapeutics

27/03/2023 12:32

* Abeona Therapeutics Inc  ABEO.OQ   ABEO.O  is expected
to show a
fall in quarterly revenue when it reports  results on March 29
(estimated). 
    * The New York City-based  company is expected to report  a
66.7% decrease in revenue to $1 million from $3 million a year
ago, according to the mean estimate from 2 analysts, based on
Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Abeona Therapeutics
Inc
is for a loss of 75 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Abeona
Therapeutics Inc is $29​, above​ its last closing price
of $2.71. ​​​

This summary was machine generated March 27 at 11:32 GMT.  All
figures in US dollars  unless otherwise stated